Search

everythinglearnresearchcommunity

for

Search:↓

Different types of hair loss are linked to COVID-19, with some types possibly increasing risk of getting the virus, while others may be triggered or worsened by the virus.

A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.

Erosive pustular dermatosis of the scalp causes painful, scarring skin lesions on the scalp, mainly in elderly people with sun-damaged skin.

Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.

Ulcerative colitis can cause skin issues due to immune system problems.

Skin health and diseases are closely linked to metabolic processes.

Myotonic Dystrophy may age cells faster, and drugs that target aging could be potential treatments.

IBD patients treated with TNF antagonists may develop autoimmune alopecia areata, with severe cases less likely to improve.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Topical minoxidil successfully treated temporal triangular alopecia.

Ezetimibe effectively reduces prostate size in cases of benign prostatic hyperplasia.

Four new cases of Bachmann-Bupp syndrome suggest potential for targeted treatment.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Alopecia affects mental health, causing depression and anxiety, but new treatments can improve both hair growth and quality of life.

Alopecia affects mental health, causing depression and anxiety, but new treatments can help improve both hair growth and quality of life.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

Targeting multiple pathways may improve treatments for androgenetic alopecia.

PCOS involves immune system issues and inflammation, possibly leading to autoimmune diseases.

Targeting the AhR pathway may help treat alopecia areata.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

Aging in one type of stem cell can cause aging-like changes in various organs.

Long COVID can cause anemia and iron issues, leading to fatigue and slow recovery, especially in men and severe cases.

Abnormal growth factor metabolism may link psoriasis and metabolic syndrome, and obesity can affect psoriasis treatment effectiveness.

NDRG1 protein helps infantile hemangioma, a common infant tumor, to grow, and its mismanagement by FOXO1 protein plays a big role in causing the tumor.

Melatonin-loaded nanoparticles improve antidepressant effects and HPA hormone balance better than regular melatonin.

Hidradenitis suppurativa is linked to autoinflammation and immune system issues.

Correcting selenium and zinc levels may help manage hair loss in autoimmune thyroiditis.

Specific miRNA profiles can help diagnose and treat alopecia areata.

Reduced AhR signaling in HS tunnels leads to persistent inflammation and microbial imbalance.